Español
Français
Deutsch
Italiano
Português
TeamUp Strategies
Runway Architecture
Decisive Intelligence
Clinical Informatics
Patient Measurement
Perspectives
Cardiology
Acute Care
Private Clinic
Emergency department
Intensive care unit
Neonatal intensive care unit
Perioperative care
Keeping caregivers safe
Clinical education
UK Pathfinder SL and Lifescreen Pro user training
eLearning
Technical training
Open a support ticket
Product manuals
Service contract
Cleaning instructions
Supplier change request
Contact us
Regional contacts
Our heritage
Senior management
News and Events
Patents and trademarks
Quality and ISO certificates
Careers
Terms and policiesSNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare, a division of OSI Systems, Inc., announces its Rothman Index clinical decision support system has received an Innovative Technology designation for its predictive analytics technology from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the country. Spacelabs Healthcare exhibited the Rothman Index at the Vizient Innovative Technology Exchange October 17 in Dallas.
Each year, healthcare experts serving on Vizient customer-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of healthcare organizations.
The Rothman® Index is an FDA cleared, widely published clinical decision support system that calculates patient acuity scores by automatically analyzing volumes of valuable patient data from the EMR, including complete head-to-toe nursing assessments. The system’s predictive analytics algorithms detect subtle changes over time that often go unnoticed, to accurately identify a patient’s physiological condition. It’s designed to assist clinicians in early detection and intervention of deteriorating patients—to help save lives.
“We are committed to driving continual innovation to support our customers in their commitment to improving patient outcomes,” said Spacelabs President Shalabh Chandra. “The Rothman Index is designed to assist clinicians in early detection and intervention of deteriorating patients to help healthcare organizations improve clinical efficiencies and realize better patient outcomes—it’s a powerful system.”
“Our customer councils reviewed and determined the Rothman Index should be recognized with an Innovative Technology designation based on its potential to make an incremental difference in health care,” said Kelly Flaharty, Vizient senior director of contract services. “Congratulations to Spacelabs Healthcare on receiving this status.”
Vizient represents a diverse customer base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers, and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with customer-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.
About Spacelabs Healthcare
Spacelabs Healthcare (www.spacelabshealthcare.com), a division of OSI Systems, Inc., is a provider of medical equipment and services, including solutions for patient monitoring and connectivity, non-invasive cardiology, and supplies and accessories selling to hospitals, clinics, and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, and Italy, and distributors in more than 100 countries around the world.
About OSI Systems
OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense, and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems or its subsidiary companies, visit www.osi-systems.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to OSI Systems’ current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside OSI Systems’ control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. OSI Systems assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause OSI Systems’ future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in OSI Systems’ most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by OSI Systems from time to time with the Securities and Exchange Commission.